BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29727497)

  • 21. Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden.
    Kozlowski P; Lennmyr E; Ahlberg L; Bernell P; Hulegårdh E; Karbach H; Karlsson K; Tomaszewska-Toporska B; Åström M; Hallböök H;
    Eur J Haematol; 2017 Aug; 99(2):141-149. PubMed ID: 28419558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.
    Parikh SA; Habermann TM; Chaffee KG; Call TG; Ding W; Leis JF; Macon WR; Schwager SM; Ristow KM; Porrata LF; Kay NE; Slager SL; Shanafelt TD
    Am J Hematol; 2015 Apr; 90(4):334-8. PubMed ID: 25581025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis.
    Landgren O; Algernon C; Axdorph U; Nilsson B; Wedelin C; Porwit-MacDonald A; Grimfors G; Björkholm M
    Haematologica; 2003 Apr; 88(4):438-44. PubMed ID: 12681971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence.
    Tarella C; Cuttica A; Vitolo U; Liberati M; Di Nicola M; Cortelazzo S; Rosato R; Rosanelli C; Di Renzo N; Musso M; Pavone E; Santini G; Pescarollo A; De Crescenzo A; Federico M; Gallamini A; Pregno P; Romano R; Coser P; Gallo E; Boccadoro M; Barbui T; Pileri A; Gianni AM; Levis A
    Cancer; 2003 Jun; 97(11):2748-59. PubMed ID: 12767087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry.
    Biasoli I; Castro N; Delamain M; Silveira T; Farley J; Pinto Simões B; Solza C; Praxedes M; Baiocchi O; Gaiolla R; Franceschi F; Bonamin Sola C; Boquimpani C; Clementino N; Fleury Perini G; Pagnano K; Steffenello G; Tabacof J; de Freitas Colli G; Soares A; de Souza C; Chiattone CS; Raggio Luiz R; Milito C; Morais JC; Spector N
    Int J Cancer; 2018 Mar; 142(5):883-890. PubMed ID: 29023692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenges of Hodgkin lymphoma in the elderly.
    Coiffier B
    Oncology (Williston Park); 2008 Nov; 22(12):1388, 1393. PubMed ID: 19322948
    [No Abstract]   [Full Text] [Related]  

  • 28. Seasonal variation in the diagnosis of Hodgkin lymphoma in Sweden.
    Chang ET; Blomqvist P; Lambe M
    Int J Cancer; 2005 May; 115(1):127-30. PubMed ID: 15660399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.
    Jalali A; Ha FJ; Chong G; Grigg A; Mckendrick J; Schwarer AP; Doig R; Hamid A; Hawkes EA
    Ann Hematol; 2016 Apr; 95(5):809-16. PubMed ID: 26878861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hodgkin's lymphoma in adolescents.
    Foltz LM; Song KW; Connors JM
    J Clin Oncol; 2006 Jun; 24(16):2520-6. PubMed ID: 16735704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
    Mauro FR; Galieni P; Tedeschi A; Laurenti L; Del Poeta G; Reda G; Motta M; Gozzetti A; Murru R; Caputo MD; Campanelli M; Frustaci AM; Innocenti I; Raponi S; Guarini A; Morabito F; Foà R; Gentile M
    Am J Hematol; 2017 Jun; 92(6):529-535. PubMed ID: 28295527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
    Torok JA; Wu Y; Prosnitz LR; Kim GJ; Beaven AW; Diehl LF; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):54-9. PubMed ID: 25863754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy.
    Olszewski AJ; Castillo JJ
    AIDS; 2016 Mar; 30(5):787-96. PubMed ID: 26730566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group.
    Engert A; Ballova V; Haverkamp H; Pfistner B; Josting A; Dühmke E; Müller-Hermelink K; Diehl V;
    J Clin Oncol; 2005 Aug; 23(22):5052-60. PubMed ID: 15955904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy.
    Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
    Am J Hematol; 2017 Mar; 92(3):251-258. PubMed ID: 28006849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients.
    Weibull CE; Björkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
    Int J Cancer; 2019 Sep; 145(5):1200-1208. PubMed ID: 30666628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.